These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26210869)

  • 1. Interventions for Diabetic Retinopathy in Type 1 Diabetes: Systematic Review and Meta-Analysis.
    Virk SA; Donaghue KC; Wong TY; Craig ME
    Am J Ophthalmol; 2015 Nov; 160(5):1055-1064.e4. PubMed ID: 26210869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis.
    Wang B; Wang F; Zhang Y; Zhao SH; Zhao WJ; Yan SL; Wang YG
    Lancet Diabetes Endocrinol; 2015 Apr; 3(4):263-74. PubMed ID: 25660574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive agents for preventing diabetic kidney disease.
    Lv J; Perkovic V; Foote CV; Craig ME; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2012 Dec; 12():CD004136. PubMed ID: 23235603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous subcutaneous insulin infusion vs multiple daily injections in pregnant women with type 1 diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials and observational studies.
    Rys PM; Ludwig-Slomczynska AH; Cyganek K; Malecki MT
    Eur J Endocrinol; 2018 May; 178(5):545-563. PubMed ID: 29545258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials.
    Chaturvedi N; Porta M; Klein R; Orchard T; Fuller J; Parving HH; Bilous R; Sjølie AK;
    Lancet; 2008 Oct; 372(9647):1394-402. PubMed ID: 18823656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure to initiate early insulin therapy - A risk factor for diabetic retinopathy in insulin users with Type 2 diabetes mellitus: Sankara Nethralaya-Diabetic Retinopathy Epidemiology and Molecular Genetics Study (SN-DREAMS, Report number 35).
    Gupta A; Delhiwala KS; Raman RP; Sharma T; Srinivasan S; Kulothungan V
    Indian J Ophthalmol; 2016 Jun; 64(6):440-5. PubMed ID: 27488152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.
    Hemmingsen B; Lund SS; Gluud C; Vaag A; Almdal TP; Hemmingsen C; Wetterslev J
    Cochrane Database Syst Rev; 2013 Nov; (11):CD008143. PubMed ID: 24214280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits of Renin-Angiotensin blockade on retinopathy in type 1 diabetes vary with glycemic control.
    Harindhanavudhi T; Mauer M; Klein R; Zinman B; Sinaiko A; Caramori ML;
    Diabetes Care; 2011 Aug; 34(8):1838-42. PubMed ID: 21715517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy, safety, and patient acceptability of Technosphere inhaled insulin for people with diabetes: a systematic review and meta-analysis.
    Pittas AG; Westcott GP; Balk EM
    Lancet Diabetes Endocrinol; 2015 Nov; 3(11):886-94. PubMed ID: 26341170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of chronic diabetes complications depending on the method of insulin therapy in children and adolescents with type 1 diabetes].
    Florys B; Ołdytowska A; Głowińska B; Peczyńska J; Urban M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(1):31-9. PubMed ID: 15355737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of insulin in type 2 diabetes: meta-analysis of randomised controlled trials.
    Erpeldinger S; Rehman MB; Berkhout C; Pigache C; Zerbib Y; Regnault F; Guérin E; Supper I; Cornu C; Kassaï B; Gueyffier F; Boussageon R
    BMC Endocr Disord; 2016 Jul; 16(1):39. PubMed ID: 27391319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin II-receptor blockers for ischemic heart disease.
    Baker WL; Coleman CI; Kluger J; Reinhart KM; Talati R; Quercia R; Phung OJ; White CM
    Ann Intern Med; 2009 Dec; 151(12):861-71. PubMed ID: 20008762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69.
    Matthews DR; Stratton IM; Aldington SJ; Holman RR; Kohner EM;
    Arch Ophthalmol; 2004 Nov; 122(11):1631-40. PubMed ID: 15534123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive insulin therapy, by The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N. Engl. J. Med 342:381-9, 2000.
    Barr CC
    Surv Ophthalmol; 2001; 45(5):459-60. PubMed ID: 11274700
    [No Abstract]   [Full Text] [Related]  

  • 15. Longer term safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus: systematic review and meta-analysis.
    Gooßen K; Gräber S
    Diabetes Obes Metab; 2012 Dec; 14(12):1061-72. PubMed ID: 22519906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The retinal renin-angiotensin system: implications for therapy in diabetic retinopathy.
    Sjølie AK; Chaturvedi N
    J Hum Hypertens; 2002 Aug; 16 Suppl 3():S42-6. PubMed ID: 12140727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diabetes self-management and its association with diabetic retinopathy in patients with type 2 diabetes].
    Li N; Yang XF; Deng Y; Gu H; Ren XT; Xu J; Ma K; Liu NP
    Zhonghua Yan Ke Za Zhi; 2013 Jun; 49(6):500-6. PubMed ID: 24119962
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.